Added Value of Female-Specific Factors Beyond Traditional Predictors for Future Cardiovascular Disease

[...]we aimed to evaluate the added value of female-specific factors in addition to traditional risk factors for the prediction of 10-year risk of CVD in women. <4 2,288 (20.1) 1.00 (0.88-1.12) 559 (7.7) 0.97 (0.72-1.31) Gestational hypertension 4,345 (30.9) 1.07 (0.96-1.19) 1,318 (18.3) 1.01 (0....

Full description

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 67; no. 17; pp. 2084 - 2086
Main Authors van der Meer, Manon G., van der Graaf, Yolanda, Schuit, Ewoud, Peelen, Linda M., Verschuren, W.M. Monique, Boer, Jolanda M.A., Moons, Karel G.M., Nathoe, Hendrik M., Appelman, Yolande, van der Schouw, Yvonne T.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 03.05.2016
Elsevier Limited
Subjects
Online AccessGet full text
ISSN0735-1097
1558-3597
1558-3597
DOI10.1016/j.jacc.2016.02.031

Cover

More Information
Summary:[...]we aimed to evaluate the added value of female-specific factors in addition to traditional risk factors for the prediction of 10-year risk of CVD in women. <4 2,288 (20.1) 1.00 (0.88-1.12) 559 (7.7) 0.97 (0.72-1.31) Gestational hypertension 4,345 (30.9) 1.07 (0.96-1.19) 1,318 (18.3) 1.01 (0.79-1.30) Gestational diabetes 511 (3.6) 0.99 (0.74-1.32) 191 (2.6) 0.76 (0.38-1.53) Table 1 Female-Specific Risk Factors: Prevalence and HRs for CVD Adjusted for Traditional Risk Factors CI = confidence interval; HR = hazard ratio; HT = hormone therapy; MORGEN = Monitoring Project on Risk Factors for Chronic Diseases; OC = oral contraceptive.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Correspondence-1
ISSN:0735-1097
1558-3597
1558-3597
DOI:10.1016/j.jacc.2016.02.031